https://scholars.lib.ntu.edu.tw/handle/123456789/593844
標題: | Evaluation of antitumor immunity by a combination treatment of high-dose irradiation, anti-PDL1, and anti-angiogenic therapy in murine lung tumors | 作者: | JENNY LING-YU CHEN Pan, C.-K. YU-SEN HUANG Tsai, C.-Y. CHUN-WEI WANG Lin, Y.-L. SUNG-HSIN KUO Shieh, M.-J. MING-JIUM SHIEH |
公開日期: | 2021 | 出版社: | Springer Science and Business Media Deutschland GmbH | 卷: | 70 | 期: | 2 | 起(迄)頁: | 391-404 | 來源出版物: | Cancer Immunology, Immunotherapy | 摘要: | C57BL/6 mice implanted in the flank with murine Lewis lung carcinoma cells were randomized into control, anti-angiogenic, anti-PD-L1, radiotherapy (RT), RT + anti-angiogenic, RT + anti-PD-L1, and RT + anti-PD-L1 + anti-angiogenic therapy groups. Immune re |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85089036100&doi=10.1007%2fs00262-020-02690-w&partnerID=40&md5=e94e5572ad49a84d91034ef0c42245cd https://scholars.lib.ntu.edu.tw/handle/123456789/593844 |
ISSN: | 0340-7004 | DOI: | 10.1007/s00262-020-02690-w | SDG/關鍵字: | antineoplastic monoclonal antibody; bevacizumab; echo contrast medium; programmed death 1 ligand 1; usphere prime; angiogenesis inhibitor; programmed death 1 receptor; additive effect; animal cell; animal experiment; animal model; animal tissue; antiangio |
顯示於: | 腫瘤醫學研究所 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。